Наукові праці. Кафедра внутрішньої медицини № 1
Permanent URI for this collectionhttps://repo.knmu.edu.ua/handle/123456789/1251
Browse
Item Arterial hypertension and non-alcoholic fatty liver disease: adipokine activity(2017) Goptsii, Olena; Buriakovska, Olena; Vovchenko, Maryna; Reznik, LarisaThe leptin level, TNF-α and the HOMA-IR index (leptin 12.73±0.82 ng/ml, female patients: 12.93±0.99 ng/ml, male patients: 11.92±1.23 ng/ml; TNF-α 8.40±0.44 mg/ml; HOMA-IR index 4.09±0.49 CU) were significantly higher in the patients patients with AH and NAFLD with AO than such of the patients with AH and NAFLD without AO: (leptin 6.66±0.48 ng/ml, female patients: 6.25±1.19 ng/ml, male patients: 6.78±0.53 ng/ml; TNF-α 5.31±0.37 ng/ml; HOMA-IR index 2.0±0.22 CU). Conclusion. The levels of leptin, TNF-α and insulin resistance index were elevated statistically significant in patients with AH and NAFLD with AO.Item Correlation between vascular remodeling and level of adipokine visfatin in hypertensive patients combined with abdominal obesity(2015-03) Andrieieva, AnastasiiaAim of the study is to optimize diagnosis of hypertensive patients combined with abdominal obesity (AO) and without it based on the determined effect of visfatin on vascular lesions. Methods. A total patients were completed 84 hypertensive patients which were separated on the first group patients with hypertension (n=25) and the second group of hypertensive patients with AO (n=59), the third group were control of apparently healthy individuals (n=17). Patients matched for age and sex. ELISA «RayBioteeh», USA was determined the level of visfatin in the serum. Structural condition of the common carotid artery evaluated by measuring the intima-media complex (IMC) of common carotid artery (CCA) used the echocardiography on the diagnostic complex «Ultrasound scanner» (USA). . Result. The systolic blood pressure (SBP) was completed (177,8±3,7) mm Hg for hypertensive patients with abdominal obesity and hypertensive patients for (166,4±2,9) mm Hg (p<0.05). In patients with abdominal obesity the level of visfatin significantly different from the control group by (33,9±1,47) ng/ml and (17,51±0,96) ng/ml (p<0.05), while in the group of hypertensive patients (24,27±1,2) ng/ml, significant differences were not found. Visfatin levels in hypertensive patients with AO (25,43±1,48) ng/ml, in contrast to patients with hypertension (19,49 ± 1,16) ng/ml, even at normal of IMC of the CCA were significantly different from the control group (p<0.05). Established a positive correlation between visfatin and IMC of the CCA in hypertension with abdominal obesity (r=0,49) and without (r=0,41), p <0,05. Conclusion. The results shows that elevated serum visfatin levels are early lesion of the vascular bed makes higher levels of visfatin compared with the control group with hypertension and AO on a background of normal IMC of the vascular wall.Item Visfatin level in hypertensive patients with abdominal obesity against the combination of anti-hypertensive therapy and atorvastatin(2014-09) Andrieieva, AnastasiiaThe treatment of hypertensive patients with abdominal obesity and dyslipidemia considering the dynamics of the visfatin level in the blood serum receiving combination of anti-hypertensive therapy and atorvastatin is relevant.